Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-21-000114

President and CEO sold 18,333 shares at an average $44.92 ($823,581)

From the SEC's structured data for this filing

Trades in this filing

Watts Ryan J. · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-12-01 Sale : show line 1 in the form −8,516 $44.39 $378,025 2,113,185 I
2021-12-01 Sale : show line 2 in the form −9,012 $45.30 $408,244 2,104,173 I
2021-12-01 Sale : show line 3 in the form −805 $46.35 $37,312 2,103,368 I
Open-market sales · 18,333 sh · avg $44.92 · $823,581
Loading xslF345X03/wf-form4_163856660331306.xml…